ArticleScientific reports2026
Intelligent malware detection on Android smartphones via a hybrid approach using gradient boosting and convolutional neural network.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Malware is malicious software that infiltrates systems without user consent. Effective detection involves identifying such software and distinguishing it from benign programs. While machine learning has shown promise in malware detection, many existing techniques demand extensive feature engineering and representation, leading to higher computation times and error rates. To address these limitations, we propose CNN-GBM, a hybrid model combining Convolutional neural networks (CNN) with Gradient Boosted Machines (GBM), aimed at improving Android malware detection. The approach begins by constructing a dataset comprising malware and benign files, represented as numerical feature vectors through n-grams, opcode sequences, or byte-level features. CNN processes the raw data to learn hierarchical patterns, while an entropy-based feature selection technique identifies the most informative attributes. These selected features are then fed into the GBM, trained to classify files as malware or benign. Evaluation using metrics such as accuracy, precision, F1 score, and false positive rate indicates that CNN-GBM outperforms existing deep learning models. Notable improvements include accuracy (+ 3%), precision (+ 1%), recall (+ 5%), AUC (+ 3.5%), and significant reductions in false positive rate (- 52%), false negative rate (- 15%), and error rate (- 35%). These enhancements stem from the effective integration of CNN feature extraction with GBM's boosting capabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.